ADMA Biologics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. 

CEO
Adam S. Grossman
CEOAdam S. Grossman
Employees
647
Employees647
Headquarters
Ramsey, New Jersey
HeadquartersRamsey, New Jersey
Founded
2004
Founded2004
Employees
647
Employees647

ADMA Key Statistics

Market cap
2.92B
Market cap2.92B
Price-Earnings ratio
16.96
Price-Earnings ratio16.96
Dividend yield
—
Dividend yield—
Average volume
3.17M
Average volume3.17M
High today
$13.47
High today$13.47
Low today
$13.13
Low today$13.13
Open price
$13.26
Open price$13.26
Volume
2.45M
Volume2.45M
52 Week high
$20.46
52 Week high$20.46
52 Week low
$7.21
52 Week low$7.21

Stock Snapshot

As of today, ADMA Biologics(ADMA) shares are valued at $13.30. The company's market cap stands at 2.92B, with a P/E ratio of 16.96.

During the trading session on 2026-11-22, ADMA Biologics(ADMA) shares reached a daily high of $13.47 and a low of $13.13. At a current price of $13.30, the stock is +1.3% higher than the low and still -1.3% under the high.

Trading volume for ADMA Biologics(ADMA) stock has reached 2.45M, versus its average volume of 3.17M.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $20.46 and a low of $7.21.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $20.46 and a low of $7.21.

ADMA News

Investing.com 5d
ADMA Biologics director sells $139,200 in company stock - Investing.com

...

ADMA Biologics director sells $139,200 in company stock - Investing.com
Simply Wall St 6d
Is ADMA Biologics Undervalued On Strong Q3 Results And Reaffirmed 2026 Guidance?

ADMA Biologics (ADMA) drew fresh attention after reporting third quarter 2026 results with higher sales and net income than a year earlier, while reaffirming at...

Is ADMA Biologics Undervalued On Strong Q3 Results And Reaffirmed 2026 Guidance?
Simply Wall St 7d
Is Earnings And Guidance Reaffirmed Altering The Investment Case For ADMA Biologics?

ADMA Biologics reported third quarter 2026 sales of US$141.1 million and net income of US$49.88 million, while reaffirming at least US$530 million in full year...

Is Earnings And Guidance Reaffirmed Altering The Investment Case For ADMA Biologics?

People also own

Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.